The African Journal of Laboratory Medicine, ISSN 2225-2002, e-ISSN 2225-2010, is a premier publication dedicated to advancing the field of laboratory medicine within the African context. Published by AOSIS since 2012, this Open Access journal aims to disseminate influential research findings, clinical studies, and innovative techniques in the realms of Clinical Biochemistry, Medical Laboratory Technology, and Public Health. Based in South Africa, the journal not only serves as a critical platform for sharing knowledge and best practices but also plays a significant role in fostering public health discussions relevant to the continent. Over the years, it has established itself with impactful rankings in various categories, including a Q4 in Clinical Biochemistry and Q3 in both Medical Laboratory Technology and Public Health. As such, it caters to a diverse audience of researchers, professionals, and students eager to stay at the forefront of laboratory medicine research and its applications. The journal’s commitment to quality and accessibility positions it as an essential resource for those looking to make a significant impact in their respective fields.

Annals of Laboratory Medicine, published by the KOREAN SOC LABORATORY MEDICINE, stands as a pivotal resource for researchers and practitioners in the fields of clinical and medical biochemistry. With a strong Q2 ranking in both Biochemistry (medical) and Clinical Biochemistry, along with a prestigious Q1 status in miscellaneous Medicine categories, this journal emphasizes the significance of laboratory medicine in improving patient outcomes and advancing scientific understanding. Established in 2012, the journal has demonstrated an impressive trajectory of growth and scholarly contribution, making it a reliable source of high-quality research and insightful reviews. The journal utilizes open access, enhancing the reach of its findings across the global scientific community. Operating from South Korea, Annals of Laboratory Medicine aims to foster dialogue and collaboration among professionals, contributing to the continuous advancement of laboratory methodologies and diagnostics.

Laboratory Investigation is a premier academic journal published by Elsevier Science Inc, specializing in the fields of Pathology, Forensic Medicine, Cell Biology, and Molecular Biology. With its ISSN 0023-6837 and E-ISSN 1530-0307, this journal has been a significant contributor to scientific discourse since its inception in 1952, converging into its current form by 2024. It holds an impressive standing in its respective fields, featuring a 2023 Journal Rank of Q2 in both Cell Biology and Molecular Biology, and an elite Q1 ranking in Pathology and Forensic Medicine, reflecting its influence and quality of research, as seen in its Scopus ranks—17th out of 208 in Pathology and Forensic Medicine. Although it does not offer Open Access options, the journal remains a vital resource for researchers, professionals, and students who seek to disseminate and engage with high-caliber research findings. The importance of Laboratory Investigation is underscored by its commitment to advancing the understanding of laboratory and translational medicine, paving the way for innovations that enhance clinical practices.

Revista Romana de Medicina de Laborator is a prominent open-access journal published by SCIENDO, dedicated to the field of medical laboratory technology and biochemistry. Since its inception, this journal has been a vital platform for disseminating research findings and advancements in laboratory medicine. With an ISSN of 1841-6624 and E-ISSN 2284-5623, it has served the academic community since 2008 and has embraced an open-access model since 2013, ensuring that valuable research is accessible to all. While it features niche rankings in Scopus for areas such as Medical Laboratory Technology and Clinical Biochemistry, it consistently strives to engage researchers, professionals, and students. Its rich collection of articles highlights innovative techniques and methodologies, supporting the ongoing development of laboratory practices. Although its coverage in Scopus has been discontinued, the journal continues to publish high-quality studies that contribute significantly to the field, fostering knowledge exchange essential for advancing medical science.

ANNALS OF CLINICAL AND LABORATORY SCIENCE, published by the Association of Clinical Scientists, is a pivotal journal in the fields of clinical biochemistry, hematology, immunology, and medical laboratory technology. Since its inception in 1971, this journal has become a vital resource for researchers and practitioners aiming to advance their knowledge and skills in laboratory sciences. Although currently not an open access journal, its rich repository of peer-reviewed articles and studies contributes significantly to the academic discourse in diagnostic and therapeutic practices. The journal is categorized in various quartiles, reflecting its impact and contributions to multiple scientific domains, such as Q4 in Clinical Biochemistry and Q3 in Pathology and Forensic Medicine as of 2023. With an extensive convergence of years up to 2024, it proves to be a timeless source for emerging trends and research innovations. The ANNALS OF CLINICAL AND LABORATORY SCIENCE not only supports the professional development of its readers but also encourages interdisciplinary collaboration, making it an essential tool for professionals, students, and researchers dedicated to improving health outcomes through advanced laboratory sciences.

The American Journal of Clinical Pathology, published by Oxford University Press Inc, stands as a vital resource in the fields of pathology and clinical medicine. With a rich history dating back to 1945 and an impressive impact factor reflected in its Q1 ranking in Pathology and Forensic Medicine, this journal serves as a cornerstone for researchers and professionals seeking to advance their knowledge and practice. Covering a breadth of topics within the discipline, it is recognized in 2023 as ranked #24 out of 208 in its category, highlighting its esteemed reputation within the scientific community. Although the journal does not currently offer open access, its rigorous peer-reviewed articles and cutting-edge research make it an essential addition to any academic or clinical library. The ISSN for print version is 0002-9173, with an E-ISSN of 1943-7722 available for digital access. Researchers, students, and practitioners alike will benefit from its comprehensive scope and commitment to disseminating high-quality scientific inquiry.

Advances in Laboratory Medicine - Avances en Medicina de Laboratorio is a distinguished open-access journal published by Walter de Gruyter GmbH, dedicated to the field of medical laboratory technology and the broader aspects of laboratory medicine. Launched in 2020, this journal aims to disseminate high-quality research, innovative methodologies, and critical reviews that foster advancements in laboratory practices. With significant rankings, including Q3 in Medical Laboratory Technology and Q4 in Education and Medicine (miscellaneous) as of 2023, it serves as a vital resource for researchers, professionals, and students interested in enhancing their understanding and implementation of laboratory protocols. Based in Germany, the journal not only emphasizes accessibility through its open-access model but also contributes significantly to the evolving landscape of medical laboratory science. Join a community of scholars striving to improve patient outcomes and elevate standards within the laboratory domain.

Recent Advances in Inflammation & Allergy Drug Discovery, published by Bentham Science Publishers Ltd, is an esteemed open-access journal dedicated to the dynamic fields of drug discovery, immunology, and allergy. Since its inception in 2021, this journal has emerged as a crucial platform for disseminating groundbreaking research and innovative methodologies that drive forward our understanding of inflammatory processes and allergic diseases. With an ISSN of 2772-2708 and an E-ISSN of 2772-2716, it is currently indexed in various categories, boasting a Q3 ranking in Drug Discovery and Immunology & Allergy, and a Q1 ranking in Medicine (miscellaneous) for 2022. Operating from the United Arab Emirates, the journal aims to bridge the gap between laboratory research and clinical application, offering a comprehensive collection of articles that are accessible to a broad audience. Through its commitment to open access, it ensures that critical findings are widely available, fostering collaboration and innovation among researchers, practitioners, and students alike. Join the scholarly community engaged in this vital area of research and contribute to the ongoing advancements in inflammation and allergy therapeutics.

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.

IN VIVO is a prestigious academic journal published by the International Institute of Anticancer Research, dedicated to advancing the fields of biochemistry, genetics, molecular biology, cancer research, and pharmacology. With its ISSN 0258-851X and E-ISSN 1791-7549, this journal has been a key contributor to innovative research since its inception in 1987, providing a crucial platform for the dissemination of significant findings in its scope. With an impressive impact reflected in its quartile rankings (Q2 in Biochemistry, Genetics and Molecular Biology and Medicine; Q3 in Cancer Research and Pharmacology), IN VIVO reaches a global audience comprising researchers, health professionals, and students. Although it operates on a subscription basis, the journal’s commitment to scientific excellence and rigorous peer review ensures that all published works maintain high quality and relevance. Notably positioned in Scopus ranks within the 36th to 59th percentiles across various categories, IN VIVO continues to be a vital resource for cutting-edge research and developments, solidifying its importance within the scientific community.